Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate
Keywords: کمی; Sphingosine-1-phosphate (S1P); Phosphate compound; Blood lysate; Quantitative; Bioanalysis; LC-MS/MS; Phosphatase inhibitor; Kinase inhibitor;